Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease

Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE ® smallpox vaccine

(2015) Jesse D. Troy et al.   VACCINE

Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease

(2015) Eric M. Mucker et al.   PLoS One

Discovery of forgotten variola specimens at the National Institutes of Health in the USA

(2014) Isao Arita   Expert Review of Anti-Infective Therapy

Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox)

(2013) Eric M. Mucker et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical development of Modified Vaccinia virus Ankara vaccines

(2013) Sarah C. Gilbert   VACCINE

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

(2012) Jarasvech Chinsangaram et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Lethal Monkeypox Virus Infection of CAST/EiJ Mice Is Associated with a Deficient Gamma Interferon Response

(2012) P. L. Earl et al.   JOURNAL OF VIROLOGY

Side-by-Side Comparison of Gene-Based Smallpox Vaccine with MVA in Nonhuman Primates

(2012) Joseph W. Golden et al.   PLoS One

Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults

(2011) J. S. Kennedy et al.   JOURNAL OF INFECTIOUS DISEASES

Smallpox Vaccine Safety Is Dependent on T Cells and Not B Cells

(2011) Shari N. Gordon et al.   JOURNAL OF INFECTIOUS DISEASES

Control of vaccinia virus skin lesions by long-term-maintained IFN-γ+TNF-α+ effector/memory CD4+ lymphocytes in humans

(2010) Bénédicte Puissant-Lubrano et al.   JOURNAL OF CLINICAL INVESTIGATION

Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo

(2010) A. W. Rimoin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

(2009) R. Jordan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246

(2009) J. Huggins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gender effects on humoral immune responses to smallpox vaccine

(2009) Richard B. Kennedy et al.   VACCINE